To highlight Rare Disease Day on 29th February, French cosmetics and pharmaceutical business Pierre Fabre Laboratories, shared more on its work to address rare childhood diseases, which it said affects more than 200 million children worldwide.
Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Pierre Fabre Laboratories, Committed To Combating Rare Pediatric Diseases Via Innovative Therapies menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
The findings are from a post-hoc analysis of phase 2 and 3 clinical trial data from the study that showed propranolol was effective in the treatment of infantile hemangioma.